Angel News
Angel News
Angel News

Back to Homepage

24th August 2018

Orchard Therapeutics Announces $150 Million Series C Financing

UCLTF funded Orchard Therapeutics, a biotechnology company dedicated to transforming the lives of patients with rare disorders through innovative gene therapies, has announced the completion of an oversubscribed $150 million Series C financing.  Deerfield Management led the financing with significant new investments from RA Capital Management, Venrock, Foresite Capital, Perceptive Advisors, Cormorant Asset Management LP, ArrowMark Partners, Sphera Global Healthcare, Medison Ventures, Driehaus Capital Management and Ghost Tree Capital Group, LP, as well as additional U.S. based healthcare focused funds. Existing investors also participated including Temasek, Baillie Gifford, RTW Investments, LP, Cowen Healthcare Investments and Agent Capital.

...

Register now to read full story

In order to read the full story we need you to register with us, please click the link below:

Register Now

Add a comment:

Name:

Email:

Comment:

Enter the characters in the image shown:



Back to Homepage